Upload Avatar (500 x 500)
Wuyuan Lu
luwuyuan@fudan.edu.cn
English, Chinese
Shanghai
Fudan University
Basic Medical Sciences
  • 1980.09—1984.07 Bachelor's in Analytical Chemistry: Nanjing University
  • 1987.09—1989.12 Master's in Biochemistry: Nanjing University
  • 1992.02—1994.12 Graduate studies in Biochemistry: Purdue University
  • 1984.07—1987.08 - Nanjing Institute of Dermatology - Assistant Researcher
  • 1990.02—1992.01 - Purdue University - Research Assistant
  • 1995.07—1996.12 - Scripps Research Institute - Postdoctoral Fellow
  • 1997.01—1998.06 - Gryphon Sciences - Senior Scientist and Director of Protein Chemistry
  • 1998.07—2000.06 - University of Chicago - Assistant Professor (Research)
  • 2000.07—2007.06 - University of Maryland Biotechnology Institute - Assistant Professor, Associate Professor (Tenured)
  • 2007.07—2009.06 - University of Maryland School of Medicine - Associate Professor (Tenured)
  • 2009.07—2020.06 - University of Maryland School of Medicine - Professor (Tenured), Researcher at Institute of Human Virology, Researcher at Greenebaum Cancer Center
  • 2012.01—2017.01 - Xi'an Jiaotong University - Distinguished Professor
  • 2012.01—2015.04 - Xi'an Jiaotong University Institute of Frontier Science and Technology - Director of Translational Medicine Research Center
  • 2013.06—2015.03 - Xi'an Jiaotong University School of Life Science and Technology - Vice Dean
  • 2014.07—2020.06 - University of Maryland School of Medicine Institute of Human Virology - Director of Basic Science Division
  • 2018.07—2020.06 - University of Maryland School of Medicine Institute of Human Virology - Deputy Director
  • 2020.08—Present - Fudan University School of Basic Medical Sciences - Distinguished Professor
  • Ely Lilly Travel Award (1992): American Protein Society
  • Ismail Interdisciplinary Doctoral Research Award (1993): Purdue University
  • Special Lecturer Award (2007): Auburn University
  • Research Scholar Award (2007): American Cancer Society
  • Science and Technology Award Second Prize (2014): Chinese Pharmaceutical Association
Structure, function, and molecular mechanism of antimicrobial peptides—defensins
Discovery of anti-tumor and anti-infection drugs
Pathogen infection and pathogenic mechanisms
Total chemical synthesis and post-translational modification of proteins
  • Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3, Wu, Z., et al., 2003
  • Productive folding of human neutrophil alpha-defensins in vitro without the pro-peptide, Wu, Z., R. Powell, and W. Lu, 2003
  • Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation, Wu, Z., et al., 2004
  • Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX, Pazgier, M., et al., 2009
  • D-peptide inhibitors of the p53-MDM2 interaction for targeted molecular therapy of malignant neoplasms, Liu, M., et al., 2010
  • A left-handed solution to peptide inhibition of the p53-MDM2 interaction, Liu, M., et al., 2010
  • Human alpha-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets, Chu, H., et al., 2012
  • Human enteric alpha-defensin 5 promotes Shigella infection by enhancing bacterial adhesion and invasion, Xu, D., et al., 2018
  • Tanshinones: first-in-class inhibitors of the biogenesis of the type 3 secretion system needle of Pseudomonas aeruginosa for antibiotic therapy, Feng, C., et al., 2019
  • Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for p53 activation and tumor suppression, Li, X., et al., 2021
Antimicrobial Peptides Defensins Structure Function Molecular Mechanism Anti-Tumor Anti-Infection Pathogen Chemical Synthesis Post-Translational Modification

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.